Pharma: Other News To Note
Wednesday, June 13, 2012
Astellas Pharma Inc., of Tokyo, and the Drugs for Neglected Diseases initiative (DNDi) agreed to collaborate on drug discovery research for leishmaniasis, Chagas disease and sleeping sickness.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.